JUN and neoplasm: An experimental study demonstrated that TAM67 (dominant-negative c-Jun), an inhibitor of the transcription factor AP-1, reduced tumor progression not only through the modulation of the expression of genes involved in inflammation, invasion and metastasis, but also through Wnt5a reduction, whose role in the maintenance of tumor phenotype was previously observed.